Detalles de la búsqueda
1.
Interleukin-1 in monocyte activation phenotypes in systemic juvenile idiopathic arthritis: Observations from a clinical trial of rilonacept, an interleukin-1 inhibitor.
Clin Immunol
; 194: 9-18, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29928998
2.
HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis.
Proc Natl Acad Sci U S A
; 112(52): 15970-5, 2015 Dec 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-26598658
3.
Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications.
Ann Rheum Dis
; 76(5): 906-913, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27927641
4.
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
Ann Rheum Dis
; 75(3): 481-9, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26865703
5.
Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein.
Ann Rheum Dis
; 73(3): 557-66, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23436914
6.
Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis.
Arthritis Rheum
; 64(6): 2012-21, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22183975
7.
Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series.
Arthritis Rheum
; 63(2): 545-55, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21280009
8.
Effects of long-term etanercept treatment on growth in children with selected categories of juvenile idiopathic arthritis.
Arthritis Rheum
; 62(11): 3259-64, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20669280
9.
2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications.
Arthritis Rheum
; 65(10): 2499-512, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24092554
10.
Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus.
J Rheumatol
; 46(2): 190-197, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30275259
11.
Update on biologics in juvenile idiopathic arthritis.
Curr Opin Rheumatol
; 20(5): 613-8, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18698187
12.
Delays to Care in Pediatric Lupus Patients: Data From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry.
Arthritis Care Res (Hoboken)
; 70(3): 420-427, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28544820
13.
IL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic Arthritis.
Arthritis Rheumatol
; 70(8): 1319-1330, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29609200
14.
Juvenile idiopathic arthritis.
Rheum Dis Clin North Am
; 33(3): 441-70, vi, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17936173
15.
The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months.
Pediatr Rheumatol Online J
; 15(1): 30, 2017 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-28416023
16.
Chronic leg ulceration as the presenting feature of diffuse systemic sclerosis in childhood.
J Pediatr
; 159(4): 698, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21784448
17.
Canakinumab for the treatment of active systemic juvenile idiopathic arthritis.
Expert Rev Clin Pharmacol
; 9(8): 1015-24, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27367267
18.
Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab.
Arthritis Rheumatol
; 68(1): 218-28, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26314396
19.
Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
RMD Open
; 2(1): e000161, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26848401
20.
2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.
Arthritis Rheumatol
; 68(3): 566-76, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26314788